Outlook Therapeutics
OTLK
OTLK
75 hedge funds and large institutions have $29.6M invested in Outlook Therapeutics in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 76 → 75 (-1)
Holders
75
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.59M | |
| 2 | +$205K | |
| 3 | +$119K | |
| 4 |
Goldman Sachs
New York
|
+$100K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$59.8K |
Top Sellers
| 1 | -$163K | |
| 2 | -$159K | |
| 3 | -$130K | |
| 4 |
Renaissance Technologies
New York
|
-$61K |
| 5 |
GL
Graypoint LLC
Albany,
New York
|
-$46K |